Veru
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.About VERU
Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.
CEOMitchell Shuster Steiner
CEOMitchell Shuster Steiner
Employees210
Employees210
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded1971
Founded1971
Employees210
Employees210
VERU Key Statistics
Market cap38.86M
Market cap38.86M
Price-Earnings ratio-1.24
Price-Earnings ratio-1.24
Dividend yield—
Dividend yield—
Average volume119.05K
Average volume119.05K
High today$2.55
High today$2.55
Low today$2.38
Low today$2.38
Open price$2.46
Open price$2.46
Volume83.82K
Volume83.82K
52 Week high$14.20
52 Week high$14.20
52 Week low$2.11
52 Week low$2.11
Stock Snapshot
The current Veru(VERU) stock price is $2.40, with a market capitalization of 38.86M. The stock trades at a price-to-earnings (P/E) ratio of -1.24.
On 2025-12-04, Veru(VERU) stock moved within a range of $2.38 to $2.55. With shares now at $2.40, the stock is trading +0.9% above its intraday low and -5.8% below the session's peak.
Trading volume for Veru(VERU) stock has reached 83.82K, versus its average volume of 119.05K.
Over the past 52 weeks, Veru(VERU) stock has traded between a high of $14.20 and a low of $2.11.
Over the past 52 weeks, Veru(VERU) stock has traded between a high of $14.20 and a low of $2.11.
People also own
Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.